Osteoarthritis Trial, Recruiting NCT05700682 Sponsor: Palo Alto Veterans Institute for Research Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT05700682
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the first part of the study (Diagnostic Arm):

  • People who are Veterans and currently receive their healthcare through the VA system
  • People who have had ongoing pain in their shoulder, hip, or knee for at least one year
  • People whose painful joint shows mild to moderate wear-and-tear changes on a previous X-ray, CT scan, or MRI
  • People who have already tried at least one treatment for their joint pain (such as physical therapy, anti-inflammatory medications, or steroid injections) without enough relief
  • People who have had an MRI of their painful joint ordered by a healthcare provider

For the second part of the study (Therapeutic Arm):

  • People who completed the first part of the study and had a special type of MRI that measures blood flow around the joint
  • People whose blood flow MRI shows increased blood vessel activity around the painful joint, as determined by the study's lead researchers

Who may not be able to join:

For the first part of the study (Diagnostic Arm):

  • People who have had an injury to the affected joint within the last 12 weeks
  • People under 25 years of age
  • People whose joint shows severe wear-and-tear changes on imaging
  • People who have had a joint replacement or a metal implant placed inside the painful joint
  • People with a severe allergy to gadolinium, the contrast dye used in certain MRI scans
  • People with serious kidney disease or who are currently on dialysis
  • People with a history of cancer with a life expectancy of less than one year, or cancer that has spread to the bones
  • People who are currently pregnant
  • People who have a formal diagnosis of a cognitive (thinking or memory) impairment

For the second part of the study (Therapeutic Arm):

  • People with a severe allergy to iodine-based contrast dye used in certain scans
  • People with serious heart artery or limb artery disease
  • People who have a blood clotting disorder
  • People with poorly controlled type 2 diabetes or diabetes-related nerve damage
  • People with a history of seizures or serious reactions to light sedation (medication used to help patients relax during procedures)
  • People who have previously had bypass surgery on an artery in their arm or leg
  • People currently participating in another treatment-based clinical trial for chronic joint pain
  • People whose blood flow MRI did not show increased blood vessel activity around the painful joint
  • People who meet any of the exclusion criteria listed for the first part of the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sirish Kishore, MD, VA Palo Alto Health Care System

Phone: 560-493-5000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Palo Alto Veterans Institute for Research
Registry
ClinicalTrials.gov
Start date
15 July 2023
Est. completion
1 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Primary Clinical Outcome (Hip and Knee, Therapeutic Arm Only); Primary Clinical Outcome (Shoulder, Therapeutic Arm Only); Primary Imaging Outcome (Therapeutic Arm Only)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov